Literature DB >> 12049610

The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I.

Mitsunori Fukuda1.   

Abstract

The synaptotagmin-like protein (Slp) family consists of an N-terminal Rab27-binding domain and C-terminal tandem C2 motifs, and although it has been suggested to regulate Rab27-dependent membrane trafficking, such as Ca2+-regulated granule exocytosis in T-lymphocytes [Kuroda, Fukuda, Ariga and Mikoshiba (2002) J. Biol. Chem. 277, 9212-9218], little is known about the Ca2+-binding property of the Slp family. In this study, I demonstrated that the C2A domain of Slp3 exhibits Ca(2+)-dependent phospholipid-binding activity similar to that of the C2A domain of synaptotagmin I (Syt I) with regard to phospholipid selectivity, bivalent cation selectivity and effect of ionic strength. This finding was surprising because the C2A domains of other C-terminal-type (C-type) tandem C2 proteins require five conserved acidic residues in the putative Ca2+-binding loops 1 and 3 on the top of the beta-sandwich structure for their Ca2+-/phospholipid-binding activity, whereas the C2A domain of Slp3 contains only one conserved acidic residue in the putative Ca2+-binding loop 1. Site-directed mutagenesis and chimaeric analysis of the C2A domains of Syt I and Slp3 showed that Glu-336 and Glu-337 in the putative Ca2+-binding loop 1 and polybasic sequence (Lys-359, Lys-360 and Lys-361) in the beta-4 strand of the C2 structure are crucial for Ca2+-dependent phospholipid-binding activity of the Slp3 C2A domain, whereas the similar polybasic sequence in the C2A domain of Syt I is dispensable for Ca2+-dependent phospholipid-binding activity. These results indicate that the C2A domain of Slp3 is an atypical Ca2+-/phospholipid-binding machine, compared with other C-type tandem C2 proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049610      PMCID: PMC1222805          DOI: 10.1042/BJ20020484

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses.

Authors:  S Mochida; M Fukuda; M Niinobe; H Kobayashi; K Mikoshiba
Journal:  Neuroscience       Date:  1997-04       Impact factor: 3.590

2.  Synaptotagmin IX regulates Ca2+-dependent secretion in PC12 cells.

Authors:  Mitsunori Fukuda; Judith A Kowalchyk; Xiaodong Zhang; Thomas F J Martin; Katsuhiko Mikoshiba
Journal:  J Biol Chem       Date:  2001-12-21       Impact factor: 5.157

3.  Calcium-dependent phospholipid binding to the C2A domain of a ubiquitous form of double C2 protein (Doc2 beta).

Authors:  T Kojima; M Fukuda; J Aruga; K Mikoshiba
Journal:  J Biochem       Date:  1996-09       Impact factor: 3.387

4.  The first C2 domain of synaptotagmin is required for exocytosis of insulin from pancreatic beta-cells: action of synaptotagmin at low micromolar calcium.

Authors:  J Lang; M Fukuda; H Zhang; K Mikoshiba; C B Wollheim
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

Review 5.  The function of inositol high polyphosphate binding proteins.

Authors:  M Fukuda; K Mikoshiba
Journal:  Bioessays       Date:  1997-07       Impact factor: 4.345

6.  Regulation by bivalent cations of phospholipid binding to the C2A domain of synaptotagmin III.

Authors:  M Fukuda; T Kojima; K Mikoshiba
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

7.  The evolutionary pressure to inactivate. A subclass of synaptotagmins with an amino acid substitution that abolishes Ca2+ binding.

Authors:  C von Poser; K Ichtchenko; X Shao; J Rizo; T C Südhof
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

8.  Distinct roles of C2A and C2B domains of synaptotagmin in the regulation of exocytosis in adrenal chromaffin cells.

Authors:  M Ohara-Imaizumi; M Fukuda; M Niinobe; H Misonou; K Ikeda; T Murakami; M Kawasaki; K Mikoshiba; K Kumakura
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

9.  Molecular cloning of mouse Doc2alpha and distribution of its mRNA in adult mouse brain.

Authors:  A Naito; S Orita; A Wanaka; T Sasaki; G Sakaguchi; M Maeda; H Igarashi; M Tohyama; Y Takai
Journal:  Brain Res Mol Brain Res       Date:  1997-03

10.  Rabphilin-3A: a multifunctional regulator of synaptic vesicle traffic.

Authors:  M E Burns; T Sasaki; Y Takai; G J Augustine
Journal:  J Gen Physiol       Date:  1998-02       Impact factor: 4.086

View more
  6 in total

1.  The Slp4-a linker domain controls exocytosis through interaction with Munc18-1.syntaxin-1a complex.

Authors:  Takashi Tsuboi; Mitsunori Fukuda
Journal:  Mol Biol Cell       Date:  2006-02-15       Impact factor: 4.138

Review 2.  Molecular mechanism of docking of dense-core vesicles to the plasma membrane in neuroendocrine cells.

Authors:  Takashi Tsuboi
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

Review 3.  Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.

Authors:  Prasad V Phatarpekar; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2020-02-21       Impact factor: 5.285

4.  Determination of the Rab27-Effector Binding Affinity Using a High-Throughput FRET-Based Assay.

Authors:  Raghdan Z Al-Saad; Ian Kerr; Alistair N Hume
Journal:  Methods Mol Biol       Date:  2021

5.  The actin-binding domain of Slac2-a/melanophilin is required for melanosome distribution in melanocytes.

Authors:  Taruho S Kuroda; Hiroyoshi Ariga; Mitsunori Fukuda
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.

Authors:  Alfredo Toledo-Leyva; Julio César Villegas-Pineda; Sergio Encarnación-Guevara; Dolores Gallardo-Rincón; Patricia Talamás-Rohana
Journal:  Proteome Sci       Date:  2018-02-13       Impact factor: 2.480

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.